Dr Reddy's Laboratories Ltd has said the USFDA audit of the company's API Srikakulam plant (SEZ) located in Andhra Pradesh, has been completed with no observations. The Hyderabad-based pharma major said this in a regulatory statement to the stock exchanges.
In a recent press conference, the Dr Reddy's management was hopeful of securing approvals for the facility.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.